TargEDys logo — From Probiotics to PreciBiomics

TargEDys

From Probiotics to PreciBiomics

Founded 2015 France France 2 employees Series A Total: $10.03M Biotechnology, Health Care +1

General Information

Company Name TargEDys
Founded Year 2015
Location France France +2
Employees 2
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when TargEDys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TargEDys

TargEDys is a French biotech company, established in 2015, aiming to develop precision probiotics, known as PreciBiomic solutions, to address global public health challenges. The company collaborates with prestigious French institutes such as Inserm and IGFL to translate microbiome fundamental research into applied research in probiotics. Their focus is on understanding the molecular mechanism of action of their strains and developing industrial processes and IP for science-backed probiotics. TargEDys envisions bringing the microbiome to the forefront of healthcare to leverage its potential in enhancing appetite regulation, nutritional optimization, and mental wellness. The company recently secured a €3.50M Series A investment on 12 April 2017, with participation from Pontifax, Seventure Partners, NCI, and Zaluvida Ventures. TargEDys operates in the Biotechnology, Health Care, and Medical Devices industries, with its headquarters based in France.

Taxonomy: PreciBiomic solutions, Microbiome-based innovations, Precision probiotics, Appetite regulation, Nutritional optimization, Hormone mimetic proteins, Eating disorders treatment, Protein absorption, Molecular mimetism

Services & Products

Microbiome research and development

Target Customers

Biopharmaceutical companies healthcare providers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• ••••
12 Apr 2017
Series A •••••• 3
Investor Investor Investor
14 Apr 2016
Non Equity Assistance •••••• 1
Investor
01 Jan 2015

TargEDys Alternatives & Competitors

View All Alternatives
TargEDys vs

Human Microbiome

13 employees
Biotechnology
TargEDys vs
BIOHM Health
BIOHM Health United States

The Microbiome Innovation Company

Series Unknown
23 employees
Health Care, Health and Wellness
TargEDys vs
Dakota Biotech
Dakota Biotech United States

Creating Healthy Microbiomes

8 employees
Biotechnology, Health and Wellness

FAQ About TargEDys

From Probiotics to PreciBiomics
TargEDys was founded in 2015.
TargEDys is headquartered in France.
TargEDys operates in the following industries: Biotechnology, Health Care, Medical Devices.
TargEDys has approximately 2 employees.
TargEDys has completed 3 funding rounds, raising a total of $10.03M. The latest funding stage is Series A.
TargEDys offers: Microbiome research and development.
Top alternatives and competitors to TargEDys include Bifido Co., Ltd., BIOHM Health, Dakota Biotech, SynbioTech Human Nutrition, Ombre. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TargEDys and Bifido Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TargEDys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy